Move over, chips and cookies – snacking is getting a GLP-1-era makeover.
A recent Cornell University and Numerator study found households with at least one user of GLP-1 – medications like Ozempic, Mounjaro and Zepbound – cut grocery spending by 6 per cent within six months, with higher-income households slashing nearly 9 per cent from their food bills.
So, what’s not making its way into the grocery cart?
Snacks.
According to the study, purchases of savoury and ultra-processed treats like baked goods showed some of the biggest reductions, averaging between 6.7 per cent and 11.1 per cent. Fast food also saw a decline, down 8.6 per cent.